On Nov 06, LEBEL FRANCOIS, Chief Medical Officer sold 6,963 shares of Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), with the average selling price of the stock being $8.16 per share. The total amount realized from this sold $56,825. A document was filed with the Securities and Exchange Commission to notify the public about the sold of the shares.
In addition to that, Chief Legal Officer – McGahan Keith M sold an extra 294 shares of this stock in a transaction that took place a day before, on Aug 12, with a share sold at an average of $7.77 and a total of $2,283 was realized from this transaction. After the transaction, the Chief Legal Officer – McGahan Keith M was left with 135,543 shares of the company’s stock, which is currently worth around $1053169.11.
The recent price movement of SPPI means that it is now down by -72.92% from its 52-week high and 7.87% up against its 52-week low prices. Over the past one week, the price volatility of SPPI stands at 4.92% while the volatility over the past one month is 6.83%. The beta score for this stock is 2.47. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company on 11/07/2019 published its latest quarterly earnings, with the report showing that the company recorded -0.3 earnings per share (EPS) during that period. This report was below the expectations of analysts of -0.21 by -0.09. The revenue by the firm was 250k for the quarter.
The shares of Spectrum Pharmaceuticals Inc. (SPPI) dropped by -0.60%, leading to a loss of -$0.02 per share, and saw SPPI end the trading session at $3.29 on Thursday 01/16/20. SPPI started the trading session at $3.32, before reaching a daily high of $3.40. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $3.29.
The trading volume on Thursday stood at 2041394, which was below the stock’s 3-month average volume of 2.10 million shares, out of a total 106.33M shares. As the price of the stock dipped, the market valuation of the company dropped to 372.82 million.
The shares of NantKwest Inc. (NASDAQ: NK) went up by 39.25% by the end of the recent trading session. This movement saw its price surge to close at $7.38, which was higher than the previous closing price of $5.30. Over the past one week, the price of NK has jumped by 112.07%, while it has recorded a gain of 131.35% over the past one month. Its three-month performance saw NK gain 495.16% while its six-month performance saw it surge by 485.71%. The situation is different though over the past one year, as the stock price went up by 438.69%, while its year-to-date (YTD) price performance jumped by 94.72%. The stock price has gone up by +602.86% compared to its 90-day low, while it is down -25.45% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 2,993,695 shares, with the short-term indicators averagely rating the stock as a 100% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 1,712,808 shares and the indicators have an average rating of 100% Buy. The last indicators, the long-term see NK stock with a 100-Day average volume of 910,955 shares, giving it an average rating of 100% Buy. A look at the general picture of all short, medium and long-term indicators leaves NK with an average rating of 100% Buy.
Several brokerage firms sent out their reports NK stock not long ago. In its report sent out on May 31, 2019, Citigroup lowered its ratings on NK from a Neutral to a Sell. In an earlier report on November 30, 2018, Citigroup Upgrade the stock from a Sell to a Neutral. Citigroup meanwhile in its report on October 17, 2018 Downgrade its rating of the stock from a “Sell” to “Sell”.
In related news to the company’s stock, around 5.70% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 54 institutions currently hold the NK stock. In the last quarter, a 5,558,507 NK shares were in the possession of institutions. On the other hand, the company recorded 6 new institutions who bought it their stock, while 14 institutions sold their entire NK reserve. Of the current institutions investing in the stock, 16 increased their investment while 27 decreased their investment in the stock.